JP2021514624A5 - - Google Patents

Info

Publication number
JP2021514624A5
JP2021514624A5 JP2020544261A JP2020544261A JP2021514624A5 JP 2021514624 A5 JP2021514624 A5 JP 2021514624A5 JP 2020544261 A JP2020544261 A JP 2020544261A JP 2020544261 A JP2020544261 A JP 2020544261A JP 2021514624 A5 JP2021514624 A5 JP 2021514624A5
Authority
JP
Japan
Prior art keywords
tmprss2
expression levels
cutoff value
probability score
predetermined cutoff
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020544261A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021514624A (ja
JP7662337B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/018878 external-priority patent/WO2019165021A1/en
Publication of JP2021514624A publication Critical patent/JP2021514624A/ja
Publication of JP2021514624A5 publication Critical patent/JP2021514624A5/ja
Priority to JP2025061707A priority Critical patent/JP2025096376A/ja
Application granted granted Critical
Publication of JP7662337B2 publication Critical patent/JP7662337B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544261A 2018-02-22 2019-02-21 前立腺癌の検出および治療方法 Active JP7662337B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025061707A JP2025096376A (ja) 2018-02-22 2025-04-03 前立腺癌の検出および治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862633675P 2018-02-22 2018-02-22
US62/633,675 2018-02-22
PCT/US2019/018878 WO2019165021A1 (en) 2018-02-22 2019-02-21 Methods for prostate cancer detection and treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025061707A Division JP2025096376A (ja) 2018-02-22 2025-04-03 前立腺癌の検出および治療方法

Publications (3)

Publication Number Publication Date
JP2021514624A JP2021514624A (ja) 2021-06-17
JP2021514624A5 true JP2021514624A5 (cg-RX-API-DMAC7.html) 2022-02-28
JP7662337B2 JP7662337B2 (ja) 2025-04-15

Family

ID=65686083

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020544261A Active JP7662337B2 (ja) 2018-02-22 2019-02-21 前立腺癌の検出および治療方法
JP2025061707A Pending JP2025096376A (ja) 2018-02-22 2025-04-03 前立腺癌の検出および治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025061707A Pending JP2025096376A (ja) 2018-02-22 2025-04-03 前立腺癌の検出および治療方法

Country Status (15)

Country Link
US (3) US11410748B2 (cg-RX-API-DMAC7.html)
EP (2) EP3755816B1 (cg-RX-API-DMAC7.html)
JP (2) JP7662337B2 (cg-RX-API-DMAC7.html)
KR (2) KR20260018206A (cg-RX-API-DMAC7.html)
CN (2) CN119932188A (cg-RX-API-DMAC7.html)
AU (2) AU2019224025B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020016989A2 (cg-RX-API-DMAC7.html)
CA (1) CA3091647A1 (cg-RX-API-DMAC7.html)
DK (1) DK3755816T3 (cg-RX-API-DMAC7.html)
ES (1) ES3023842T3 (cg-RX-API-DMAC7.html)
IL (1) IL276748A (cg-RX-API-DMAC7.html)
MX (2) MX2020008702A (cg-RX-API-DMAC7.html)
PL (1) PL3755816T3 (cg-RX-API-DMAC7.html)
SG (1) SG11202007922XA (cg-RX-API-DMAC7.html)
WO (1) WO2019165021A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114901819A (zh) 2019-10-10 2022-08-12 液体活检研究有限责任公司 用于生物样品和rna稳定化的组合物、方法和试剂盒
JP7757291B2 (ja) * 2020-02-06 2025-10-21 オンコホスト リミテッド 治療法応答の機械学習予測
WO2023017525A1 (en) 2021-08-11 2023-02-16 OncoHost Ltd. Predicting patient response
JP2025534688A (ja) 2022-10-12 2025-10-17 リキッド バイオプシー リサーチ リミティド ライアビリティ カンパニー 唾液において前立腺癌を検出するための方法
GB2623570B (en) * 2022-10-21 2025-07-23 Wobble Genomics Ltd Method and products for biomarker identification
KR102891032B1 (ko) * 2022-12-29 2025-12-03 재단법인대구경북과학기술원 혈액 단구세포 전사체 생체표지자를 이용한 전이성 전립선암 진단용 바이오마커 및 이의 용도
CN116908444B (zh) * 2023-09-13 2023-12-19 中国医学科学院北京协和医院 血浆max自身抗体在晚期非小细胞肺癌pd-1单抗联合化疗治疗预后预测中的应用
CN119964650B (zh) * 2024-12-24 2025-09-30 深圳大学 一种基于集成学习的基因调控网络推断方法和系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007271232A1 (en) * 2006-07-03 2008-01-10 Exonhit Therapeutics Sa Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
US20100303795A1 (en) * 2009-05-27 2010-12-02 Soerensen Karina Dalsgaard Marker of prostate cancer
IL243203A (en) * 2010-07-27 2017-04-30 Genomic Health Inc Method for using gene expression to determine prognosis of prostate cancer
DK3179393T3 (da) * 2012-01-31 2020-07-27 Genomic Health Inc Genexpressionsprofilalgoritme og -test til bestemmelse af prognosen for prostatakræft
HK1210230A1 (en) * 2012-07-20 2016-04-15 戴格努生命科学公司 Methods, kits and compositions for providing a clinical assessment of prostate cancer
US10081842B2 (en) * 2012-08-07 2018-09-25 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Prostate cancer gene expression profiles
KR20150110477A (ko) * 2012-11-20 2015-10-02 파디아 에이비 공격적인 전립선 암의 존재 또는 부존재를 나타내는 방법
PL2945628T3 (pl) * 2013-01-15 2020-09-21 Aragon Pharmaceuticals, Inc. Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
JP2016521966A (ja) * 2013-03-15 2016-07-28 メタマーク ジェネティクス， インコーポレイテッド 癌の予後のための組成物および方法
US20160130661A1 (en) * 2013-06-13 2016-05-12 University Of South Australia Methods for detecting prostate cancer
CA2920429C (en) 2013-08-06 2021-11-16 Exosome Diagnostics, Inc. Urine biomarker cohorts, gene expression signatures, and methods of use thereof
EP3214444A1 (en) * 2016-03-04 2017-09-06 AIT Austrian Institute of Technology GmbH Prostate cancer diagnostic method and means

Similar Documents

Publication Publication Date Title
JP2021514624A5 (cg-RX-API-DMAC7.html)
US20220396842A1 (en) Method for using gene expression to determine prognosis of prostate cancer
Todeschini et al. Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts
CN110546263B (zh) 用于检测卵巢肿瘤的试剂盒、装置和方法
CN119220676A (zh) 前列腺癌的检测试剂盒或装置以及检测方法
CA2623425A1 (en) Methods for diagnosing pancreatic cancer
CN106414774A (zh) 胆道癌的检测试剂盒或装置以及检测方法
US20180142303A1 (en) Methods and compositions for diagnosing or detecting lung cancers
WO2016097120A1 (en) Method for the prognosis of hepatocellular carcinoma
JP2025510477A (ja) メチル化バリアントを使用した腫瘍画分推定
Shah et al. Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer
US20230257826A1 (en) Methods for predicting prostate cancer and uses thereof
RS59161B1 (sr) Mikro-rnk biomarkeri za identifikovanje rizika i/ili dijagnostikovanje tumora pluća
Mengual et al. Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers
US11732305B2 (en) Method and kit for diagnosing early stage pancreatic cancer
WO2022103287A1 (en) Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer
JP2020528274A5 (cg-RX-API-DMAC7.html)
CN115992229B (zh) 一种胰腺癌预后风险评估的lncRNA标记物、模型及其应用
WO2019175786A1 (en) An in vitro diagnostic method for prostate cancer and related kit
CN111315897B (zh) 用于黑素瘤检测的方法
US20240093306A1 (en) Micro rna liver cancer markers and uses thereof
JP2024035040A (ja) 分析方法、キット及び検出用デバイス
WO2025105011A1 (en) Method for determining pancreatic cancer
CN119685479A (zh) 用于胰腺癌早期诊断的sEV mRNA组合标志物、其应用及检测试剂盒
Donovan et al. RADICAL PROSTATECTOMY OUTCOMES FROM A VALIDATED URINE EXOSOME GENE EXPRESSION ASSAY WHICH PREDICTS HIGH-GRADE (GS7) PROSTATE CANCER SUGGESTS UTILITY FOR MEN ENROLLED IN ACTIVE SURVEILLANCE.: MP33-05